These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A review of the use of augmentation therapy for the treatment of resistant depression: implications for the clinician. Schweitzer I; Tuckwell V; Johnson G Aust N Z J Psychiatry; 1997 Jun; 31(3):340-52. PubMed ID: 9226079 [TBL] [Abstract][Full Text] [Related]
24. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Bauer M; Bschor T; Kunz D; Berghöfer A; Ströhle A; Müller-Oerlinghausen B Am J Psychiatry; 2000 Sep; 157(9):1429-35. PubMed ID: 10964859 [TBL] [Abstract][Full Text] [Related]
25. [Augmentation strategies for therapy resistant depression - a review]. Schmauss M; Messer T Psychiatr Prax; 2007 May; 34(4):165-74. PubMed ID: 17160747 [TBL] [Abstract][Full Text] [Related]
26. [Combination therapies in antidepressive drug refractory depression--an overview]. Schmauss M; Erfurth A Fortschr Neurol Psychiatr; 1996 Oct; 64(10):390-402. PubMed ID: 9036099 [TBL] [Abstract][Full Text] [Related]
27. Augmentation strategies for inadequate antidepressant response: a review of placebo-controlled studies. Coryell W Ann Clin Psychiatry; 2000 Sep; 12(3):141-6. PubMed ID: 10984003 [TBL] [Abstract][Full Text] [Related]
28. [Lithium in the treatment of refractory depression]. Brochier T; Pascalis JG; Lôo H Encephale; 1993; 19(5):553-64. PubMed ID: 8306924 [TBL] [Abstract][Full Text] [Related]
29. Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial. Berman RM; Darnell AM; Miller HL; Anand A; Charney DS Am J Psychiatry; 1997 Jan; 154(1):37-43. PubMed ID: 8988956 [TBL] [Abstract][Full Text] [Related]
30. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder? Iovieno N; Papakostas GI J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112 [TBL] [Abstract][Full Text] [Related]
31. Possible augmentation of antidepressant response by buspirone. Jacobsen FM J Clin Psychiatry; 1991 May; 52(5):217-20. PubMed ID: 2033029 [TBL] [Abstract][Full Text] [Related]
32. Effect of pindolol and milnacipran versus milnacipran and placebo on plasma prolactin and adrenocorticotrophic hormone in depressed subjects. Isaac MB; Isaac MT Hum Psychopharmacol; 2003 Oct; 18(7):569-74. PubMed ID: 14533141 [TBL] [Abstract][Full Text] [Related]
33. The use of lithium to augment antidepressant medication. Rouillon F; Gorwood P J Clin Psychiatry; 1998; 59 Suppl 5():32-9; discussion 40-1. PubMed ID: 9635546 [TBL] [Abstract][Full Text] [Related]
35. [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy]. Erbe S; Gutwinski S; Bschor T Psychiatr Prax; 2012 Mar; 39(2):57-63. PubMed ID: 22189902 [TBL] [Abstract][Full Text] [Related]
36. [Therapy refractory depression]. Hatzinger M; Holsboer-Trachsler E Wien Med Wochenschr; 1999; 149(18):511-4. PubMed ID: 10637955 [TBL] [Abstract][Full Text] [Related]
37. Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments. Van Hunsel F; Wauters A; Vandoolaeghe E; Neels H; Demedts P; Maes M Psychiatry Res; 1996 Dec; 65(3):159-69. PubMed ID: 9029664 [TBL] [Abstract][Full Text] [Related]
40. Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants. Bauer M; Adli M; Bschor T; Pilhatsch M; Pfennig A; Sasse J; Schmid R; Lewitzka U Neuropsychobiology; 2010; 62(1):36-42. PubMed ID: 20453533 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]